FAQs - Your questions our answers

All about CBD drops and cannabinoids

In the FAQs collected here, you will find all the questions and corresponding answers that we have often been asked, both about CBD oils and other products, as well as about the shipping process and the current legal situation. Should you not find a suitable question and answer here, we would be pleased if you contact us here. We will be happy to answer your request as soon as possible.

Cannabidiol or CBD for short is a plant substance from cannabis that is used in cosmetics, food and medicine and has no psychotropic properties. Cannabis is one of the oldest useful plants and has accompanied mankind for many thousands of years.

CBD cannabis is increasingly becoming the focus of research, medicine and the media. According to the World Health Organisation (WHO), the following properties have been scientifically investigated:

Analgesic
Anti-inflammatory
Anxiety relieving and antidepressant
Uncluttering
Nerve Protective
Antioxidant
Antipsychotic

Source: World Health Organisation (2018). Cannabidiol (CBD) Critical Review Report. Expert Committee on Drug Dependence. Fortieth Meeting. Geneva, 4-7 June 2018

cannhelpstands for a quality-oriented approach to natural products, with the aim of enabling all people to lead a healthy and self-determined life. Our transparency regarding production and ingredients, combined with our many years of experience in the production of affordable CBD products, guarantees a high level of customer satisfaction. Through honest and targeted education, we help society to understand and use the many benefits of hemp. At the same time, we work completely transparently and are in constant exchange with the authorities to further improve access to CBD oil and hemp products. The continuously growing customer base over the years confirms us on our path. Become part of the CANNEXOL cannhelp community!

This limit is determined by the legislator. THC is listed as a psychotropic substance, but may be contained within Austria up to 0.3% in commercial hemp. An abuse as an addictive substance can therefore be excluded. Since in other EU member states the limit is still 0.2%, our products contain less than 0.2% THC.

At cannhelpwe take product safety very seriously. Therefore, we have our raw materials, but also our products, regularly tested by certified laboratories and also publish the results of these analyses and laboratory results in the Quality and Quality Assurance section on our homepage.

Our products are manufactured in Austria. The ingredients are exclusively carefully selected and analysed raw materials. Most of our products also contain terpenes, better known as essential oils, which give our products their special aroma.

Since 2018, all cannabinoids are subject to approval as ingredients in food due to the Novel Food Regulation. Approval at EU level is the prerequisite for marketing as food or food supplements. Until successful approval, our products remain declared as aroma products in order to comply with the current legal situation. The "Novel Food Regulation" states that foods which have not been consumed to a significant extent before 15 May 1997 are first subject to a safety assessment by the European Food Safety Authority ( EFSA ) and require approval.

As part of the EIHA Novel Food Consortium, we are working on the approval as a novel food and as an active member we advocate for legal certainty and clarity at the European level.

Source

Unsere CANNEXOL Produkte werden ausschließlich aus EU-zertifizierten Nutzhanfsorten gewonnen. Die Nutzhanfsorten sind im EU-Sortenregister freigegeben und enthalten nur geringe Spuren von Tetrahydrocannabinol (THC < 0,2%). Die Sorten unterliegen somit nicht dem Suchtmittelgesetz.
Eine Verwendung von CBD Extrakten in Aromaölen ist erlaubt, solange es aus zertifiziertem Nutzhanf gewonnen wurde und auch während der Produktion die Grenze von 0.3% Tetrahydrocannabinol (THC) nicht übersteigt, da der Missbrauch als Suchtmittel somit ausgeschlossen werden kann.
Quelle

Products to which CBD has been added are currently not yet approved for ingestion, as approval at EU level is a prerequisite for marketing. The reason for this is the so-called "Novel Food Regulation", which states that foods that were not consumed to a significant extent before 15 May 1997 are first subject to a safety assessment by the European Food Safety Authority ( EFSA ) and require approval. This does not apply to foods that already contain a natural level of CBD, such as hemp seed oil, hemp tea or hemp protein powder.
Source

The recent decisions of the United Nations (UN) to remove cannabis from List IV of the 1961 Convention and to no longer classify it as a dangerous drug in the future is based, among other things, on the recommendation of the World Health Organisation (WHO), and is intended to contribute to the recognition of the medicinal value of cannabis. In parallel, the EU Commission has already confirmed in writing to the EIHA (European Industrial Hemp Association) in December 2020 that CBD can be classified as a possible food and not as a narcotic. The European Commission is resuming the examination of applications for authorisation of CBD products and continuing that for applications already submitted. Daniel Kruse, President of the European Industrial Hemp Association, called the development groundbreaking for this industry and was pleased with the decision not to consider CBD as a drug but to qualify it as a food.
Source

It is a pleasure for cannhelp, together with other European industry leaders, to take this issue forward at this level as an active member of the EIHA Novel Food Consortium. Again, we are fully transparent and in constant exchange with the authorities to further improve access to CBD oil and hemp products in the EU.

A medicinal effect may only be attributed to approved medicinal products, as the effect and safety have been verified by studies. Already approved medicines with CBD are used for epilepsy and multiple sclerosis because CBD has anti-inflammatory and antispasmodic effects. However, this does not mean that all products with CBD have these effects and alleviate diseases.

Some manufacturers of food supplements with CBD advertise medical effects such as pain relief, a reduction in anxiety or a general improvement in health, although their products have not been approved for this purpose. In doing so, they refer to current research results with CBD, which point to a variety of possible medical applications of CBD. In doing so, these market players not only accept potentially high penalties, but also capitalise on the fear and hope of consumers.

cannhelpdoes not advertise any medicinal effect and does not give any recommendation regarding dosage and intake, as the products are aromatic oils.
Source

The endocannabinoid system (ECS) consists of two primary receptors - CB1 and CB2 - as well as a variety of lesser known receptors such as the GPR18, GPR55 and GPR119 receptors and enzymes such as FAAH (fatty acid amide hydrolase). CB1 and CB2 receptors are found throughout the body, CB1 receptors are mostly found on neurons where they regulate neuronal activity and CB2 receptors are predominantly found on immune cells. See our blog post on the endocannabinoid system for more in-depth information.

The endocannabinoid system (ECS), a complex physiological system, was first described in 1992 by a research team from the National Institute of Mental Health (NIMH, Bethesda, Maryland/USA) led by William Devane and Dr. Lumir Hanus in collaboration with the Israeli scientist Raphael Mechoulam. The ECS is an endogenous regulatory system of the nervous and immune system that can significantly influence the functions of memory, appetite, metabolism, temperature regulation, stress behaviour, immune response, pain perception and motivation. This happens through the production of endocannabinoids, such as anandamide and 2-AG, which can then bind to the receptors to have a regulating effect. CBD, along with other plant substances, can also bind to these receptors and is therefore also called a phyto-cannabinoid.

In research, there is justified hope that targeted interventions in the body's own endocannabinoid metabolism will open up new therapeutic approaches. But more research is needed for this.

See our blog post on the endocannabinoid system for more in-depth information.

CBD oils referred to as full-spectrum contain the entire phytocomplex of the commercial hemp plant. Specifically, a full-spectrum extract contains the entire range of ingredients of the hemp plant. In addition to CBD, other valuable cannabinoids such as CBDa, CBV, CBG, but also terpenes and flavonoids are included. A full-spectrum CBD oil draws from the fullness of nature - pure and unadulterated. In recent years, the term broad spectrum extract has also become popular. This is a full-spectrum extract without THC content.

You can read more about our product categories and the difference between full spectrum, broad spectrum and pure extract products in our corresponding blog post here.

According to Aristotle: "The whole is more than the sum of its parts". A plant matrix contains a variety of substances that can support each other in their effects. There are also interactions between the individual cannabinoids and between terpenes and cannabinoids.

We recommend to keep our products well closed, cool, dry and out of reach of children.

From the moment the payment arrives on our account, it usually takes 1-3 working days for shipping in AT & DE. Your order will be neutrally packed and shipped by the parcel service. Shipping to other EU countries can take up to 3-6 working days.

We offer different forms of payment:

Bank transfer
EPS bank transfer
Credit card
Cash on delivery

We ship all over Europe. Please inquire about the legal situation of CBD products in the destination country before buying. It is especially important that you pay attention to the THC limit, this is for example in Austria at 0.2% and in Germany at 0.3% THC content. Continue to the online shop

Google is your friend and there is a lot of information in non-fiction.
With our newsletter, you will receive the latest information directly to your inbox about once a month. We also keep you up to date on the cannhelp blog and our social media channels.

Yes, in the spirit of "knowledge is power" you will also find a selection of further literature in the webshop.

Cannabis - Prescription guide for doctors
von Grotenhermen / Häußermann

Cannabidiol, CBD - A natural hemp remedy
by Iris Pleyer, Michael Hlatky and Philipp Hlatky

Healing with CBD
by Leonard Leinow and Juliana Birnbaum

Cannabis medicine: A practical guide for patients
byKurt Blaas

The healing power of CBD and cannabis
Howwe can improve our health with hemp products
by Franjo Grotenhermen

It goes without saying that all personal data and other information is treated as strictly confidential by cannhelp and is kept under lock and key. The sale and disclosure of your data to third parties without your consent is excluded. Customer information is processed securely in the course of our privacy policy and the DSGVO.

Please contact us here or by phone at +41 (01) 3750170 and let us know your request. We will process your request as soon as possible.